Asthma

LQG participants show improvements in lung function, overall health, mental health, and quality of life.

Asthma may increase the likelihood of chronic migraines in patients with episodic migraines.

Normal growth in lung function in early adulthood an important factor in terms of future COPD risk.

Depression and smoking status may be valuable targets for interventions from care providers.

Guidelines recommend inhaled corticosteroids for patients who experience repeated COPD exacerbations.

Study finds interventions for patients with high anxiety could be beneficial.

Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.

Rollator produces highest walk distance and times in COPD patients.

Caregivers should be mindful of COPD patient-reported symptoms that may lead to hospitalization.

Statins may influence alterations in the airways of asthmatics during restructuring.

Roflumilast has been found to help prevent flare-ups associated with COPD.

Nucala is for use with other asthma drugs for the maintenance of patients 12 years and older.

The FDA has approved GlaxoSmithKline's mepolizumab (Nucala) as an add-on maintenance treatment for severe asthma.

Health application allows patients to report respiratory symptoms and peak flow measurements from COPD.

Drop in physical activity level linked to increased airflow obstruction.

Drugs are delivered via the low-resistance Neohaler inhaler.

Caregivers are urged to utilize adequate mental health screening approaches.

Process can improve medical care with better results for patients.

Asthma is the most chronic inflammatory disease of the airways in children.

Community level factors linked to COPD include rural residence, southern residence, and community poverty.

Grants expected to lead to development of wearable and non-wearable sensors to track environmental exposures and physiological signals in a natural environment.

The National Institutes of Health (NIH) has awarded universities about $28 million in grants to study pediatric asthma triggers.

Vitamin D deficiency may speed progression of the condition.

Roflumilast normally treats inflammatory lung diseases, but was found to dramatically inhibit tumor growth.

Inpatient hospitalization and emergency department visits are key cost drivers for patients.